ARTICLE | Company News
Panacea Pharmaceuticals, M.D. Anderson Cancer Center deal
May 10, 2004 7:00 AM UTC
Panacea and the center will collaborate to develop diagnostics and therapeutics for lung cancer based on the enzyme human aspartyl (asparaginyl) beta-hydroxylase ( HAAH). The center will provide arch...